Brian H. White
FluoroPharma Medical (United States)(US)
Publications by Year
Research Areas
Lung Cancer Research Studies, Neuroendocrine Tumor Research Advances, Cancer therapeutics and mechanisms, Heat shock proteins research, PARP inhibition in cancer therapy
Most-Cited Works
- → SIRT1 Activators Suppress Inflammatory Responses through Promotion of p65 Deacetylation and Inhibition of NF-κB Activity(2012)363 cited
- → Crystallographic structure of a small molecule SIRT1 activator-enzyme complex(2015)198 cited
- → Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung Cancer(2019)67 cited
- → Discovery of an SSTR2-Targeting Maytansinoid Conjugate (PEN-221) with Potent Activity in Vitro and in Vivo(2019)51 cited
- → Ring-Opening Metathesis/Oxy-Cope Rearrangement: A New Strategy for the Synthesis of Bicyclic Medium Ring-Containing Compounds(2003)37 cited
- → Novel Miniaturized Drug Conjugate Leverages HSP90-driven Tumor Accumulation to Overcome PI3K Inhibitor Delivery Challenges to Solid Tumors(2020)11 cited
- → (±)‐1,2‐Dialkyl‐5‐nitro‐2,3‐dihydro‐1H‐indoles by a tandem reductive amination‐SNAr reaction(2009)8 cited
- → Abstract 4484: BTP-114: An albumin binding cisplatin prodrug with improved and sustained tumor growth inhibition(2015)5 cited
- → Abstract 3674: Pentarins: Improved tumor targeting through nanoparticle encapsulation of miniaturized biologic drug conjugates(2015)5 cited
- → Molybdenum Carbonyl‐Catalyzed Alkynol Cycloisomerization: Preparation of 2‐Phenyl‐2,3‐Dihydrofuran(2003)4 cited